Integra Lifesciences Holdings Corp IART

NAS: IART | ISIN: US4579852082   26/07/2024
31,43 USD (-0,32%)
(-0,32%)   26/07/2024
Grafiek Integra Lifesciences Holdings Corp Grafiek Integra Lifesciences Holdings Corp
maandag 29 juli 2024, 13:00
Kwartaalcijfers (2de kwartaal)

Integra Lifesciences Holdings Corp in het nieuws

8 juni 2024 · KKR, CrowdStrike Holdings and GoDaddy Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600 · Persbericht

13 november 2023 · Integra Final Deadline Alert · Persbericht

13 november 2023 · SHAREHOLDER ALERT: The Law Offices of Vincent Wong Remind Integra Investors of a Lead Plaintiff Deadline of November 13, 2023 · Persbericht

11 november 2023 · SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Integra LifeSciences Holdings Corporation - IART · Persbericht

9 november 2023 · SHAREHOLDER ALERT: Levi & Korsinsky Notifies Integra LifeSciences Holdings Corporation(IART) Investors of a Class Action Lawsuit and Upcoming Deadline · Persbericht

8 november 2023 · INTEGRA SHAREHOLDER NOTICE: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Integra To Contact Him Directly To Discuss Their Options · Persbericht

7 november 2023 · SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Integra LifeSciences Holdings Corporation of a Class Action Lawsuit and a Lead Plaintiff Deadline of November 13, 2023 - (NASDAQ: IART) · Persbericht

7 november 2023 · IART Investors Have Opportunity to Lead Integra LifeSciences Holdings Corporation Securities Fraud Lawsuit · Persbericht

7 november 2023 · ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Integra LifeSciences Holdings Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - IART · Persbericht

6 november 2023 · SHAREHOLDER ALERT: The Law Offices of Vincent Wong Remind Integra Investors of a Lead Plaintiff Deadline of November 13, 2023 · Persbericht

Profiel Integra Lifesciences Holdings Corp

Gezondheidstechnologie
Medische Specialiteiten
Productie
Productie van analytische laboratoriuminstrumenten

Website: www.integralife.com

Hoofdzetel: Princeton, New Jersey vlag Verenigde Staten

CEO: Peter Arduini

Werknemers: 3.287

Aandelen Integra Lifesciences Holdings Corp

Beurswaarde: 2,48 miljard USD

Effecten: 78,80 miljoen

Winst per aandeel (12 maand):  PLUS

Koers-winstverhouding:  PLUS

Beta: 0,78

Mijn selecties